Mesalamine Tablet, Delayed Release
Product Images NDC 70771-1071

1 FDA label image from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70771-1071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

0597b64c Aa1f 42bd 8fc0 49fb44ca0124 02

0597b64c Aa1f 42bd 8fc0 49fb44ca0124 02
Mesalamine 1.2 g delayed-release tablets packaging label. The label indicates a 34-tablet count and once daily dosing. The tablets are brown, oval-shaped, and scored, marked with '711'. Manufactured by Zydus Lifesciences Limited and Cadila Healthcare Ltd., Ahmedabad, India. The label also includes storage instructions and a pharmacist dispensing note.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.